Dimed SA Distribuidora de Medicamentos PNVL3
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- BRL 10.45
- Day Range
- BRL 10.27–10.51
- 52-Week Range
- BRL 10.27–13.91
- Bid/Ask
- BRL 10.25 / BRL 10.48
- Market Cap
- BRL 1.54 Bil
- Volume/Avg
- 400,000 / 346,792
Key Statistics
- Price/Earnings (Normalized)
- 15.72
- Price/Sales
- 0.35
- Dividend Yield (Trailing)
- 2.59%
- Dividend Yield (Forward)
- 2.59%
- Total Yield
- 2.63%
Company Profile
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Core
- Total Number of Employees
- 10,284
- Website
- https://www.grupopanvel.com.br
Comparables
Valuation
|
Metric
|
PNVL3
|
PGMN3
|
HYPE3
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.72 | 48.00 | 10.91 |
Price/Book Value | 1.31 | 0.51 | 1.64 |
Price/Sales | 0.35 | 0.11 | 2.41 |
Price/Cash Flow | 4.76 | 4.18 | 10.83 |
Price/Earnings
PNVL3
PGMN3
HYPE3
Financial Strength
|
Metric
|
PNVL3
|
PGMN3
|
HYPE3
|
|---|---|---|---|
Quick Ratio | 0.74 | 0.37 | 1.31 |
Current Ratio | 1.62 | 1.39 | 1.81 |
Interest Coverage | 1.84 | 0.48 | 2.42 |
Quick Ratio
PNVL3
PGMN3
HYPE3
Profitability
|
Metric
|
PNVL3
|
PGMN3
|
HYPE3
|
|---|---|---|---|
Return on Assets (Normalized) | 3.43% | −0.16% | 7.37% |
Return on Equity (Normalized) | 8.69% | −0.58% | 15.71% |
Return on Invested Capital (Normalized) | 7.59% | 6.02% | 11.67% |
Return on Assets
PNVL3
PGMN3
HYPE3
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Hctpqyfnn | Xchvj | $720.1 Bil | |
JNJ
| Johnson & Johnson | Tnmdzvv | Mmrs | $363.9 Bil | |
MRK
| Merck & Co Inc | Lcsfmfx | Mfrw | $329.8 Bil | |
ABBV
| AbbVie Inc | Dddksktv | Hwdt | $284.8 Bil | |
AZN
| AstraZeneca PLC ADR | Hdynjkcfcb | Ltpw | $237.7 Bil | |
NVS
| Novartis AG ADR | Qcqqzcdk | Rygx | $203.4 Bil | |
RHHBY
| Roche Holding AG ADR | Jwwvtxmry | Wsnv | $202.8 Bil | |
AMGN
| Amgen Inc | Bjcwphwrvm | Xgfzs | $165.5 Bil | |
PFE
| Pfizer Inc | Nwxbtnhy | Kpwn | $159.7 Bil | |
SNY
| Sanofi SA ADR | Lpttbdcg | Gjfr | $125.1 Bil |